Endeavor

10 Things to Know For Race Day

We’re here to help you gear up for Miles for Moffitt in downtown Tampa

Nearly 40 Percent of CAR T Patients Remain in Remission

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive.

Five Fitness Tips for Cancer Patients

Prepare now to participate in Miles for Moffitt

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Cancer Could Replace Heart Disease as Leading Killer of Americans by 2020

Moffitt expert weighs in on a new study suggesting cancer may soon become the No. 1 killer in the U.S.

Lung Cancer Has a Sweet Tooth

Researchers have found that early-stage NSCLC tumors or pre-cancerous lesions can give themselves away.

Battling Tough Odds

How Women in Moffitt’s Gastrointestinal Oncology Clinic Are Paving the Way in Pancreatic Cancer Research and Treatment

Can Chemo Cause Cognitive Decline in Older Patients?

A new study shows risk may be higher for those who carry Alzheimer’s gene.

One Target: Multiple Cancers

FDA approves new drug for adults and children with rare cancers